Jana Care
Jana Care is a privately held, pre-commercial connected diagnostics company building the Aina platform — paper-based blood test strips read by a smartphone-connected optical reader — to enable prescription-based, at-home monitoring of chronic kidney disease, heart failure, and diabetes, serving clinics, health workers, and underserved patient populations across the US, India, and Singapore.
- Company typePrivate
- Founded2015
- HeadquartersBoston, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Jana Care does
Jana Care is a privately held, venture-backed connected diagnostics company headquartered in Watertown, MA, with operations in Bangalore, India, and clinical presence in Singapore. Founded by Harvard graduates (the firmographics record lists 2011; company-history materials reference 2015, likely the year operations were launched after relocating from Canada), the company has 51-100 employees and remains pre-commercial — its website explicitly states that the Aina device is not available for commercial sale and has not been cleared by the FDA. Jana Care employs 51-100 people.
The company's core offering is a connected blood diagnostic platform comprising two integrated technical components. First, paper-based dry chemistry test strips use capillary action to draw a blood sample across porous media coated with reagents, performing immunoassays, enzymatic assays, and chemical affinity tests to produce a readable signal. Second, the Aina device is a compact, smartphone-connected optical reader capable of reading both colorimetric and fluorescent modalities and supporting multiple assays on a single reader. The platform transmits results from the patient's home or clinic to a physician's device to enable telehealth visits that include diagnostic testing. Product variants include the Aina Station form factor and the Habits chronic disease management program; sub-brand naming is centered on the Aina reader.
Jana Care's business model is built around prescription-based, self-administered blood testing for chronic disease management, with stated priority applications in congestive heart failure (CHF) and chronic kidney disease (CKD) — both leading drivers of hospital readmissions — and additional demonstrated applications in diabetes and gestational diabetes. Revenue mechanics, as disclosed in the input, mix hardware sales (the Aina reader and consumable test strips) with subscription/recurring connected services for result transmission and telehealth integration; pricing is not publicly disclosed and the device is not commercially available. The company has established clinical validation and channel relationships with Massachusetts General Hospital (heart failure study, 2017), the National University Hospital in Singapore (gestational diabetes app, 2017), and Siemens Healthineers India (commercial introduction of Aina in India, 2018), and operates a Bangalore facility for manufacturing and operations support. Reported scale figures — 1,500+ clinics, 10,000+ health workers, and 200,000+ patients — appear to reflect deployment across these pilots and partnerships rather than paying-customer revenue. In November 2023, Jana Care closed a $6 million Series B financing round led by IAG Capital Partners.
Jana Care firmographics
Firmographics- Name
- Jana Care
- Legal name
- Jana Care, Inc.
- Website
- https://janacare.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Jana Care is a privately held, pre-commercial connected diagnostics company building the Aina platform — paper-based blood test strips read by a smartphone-connected optical reader — to enable prescription-based, at-home monitoring of chronic kidney disease, heart failure, and diabetes, serving clinics, health workers, and underserved patient populations across the US, India, and Singapore.
- Ownership category
- akta.pro rank
Jana Care industry classification
Industry- Product category
- Connected Diagnostic Devices
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
- akta.pro secondary industries
- Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE)
Keywords
Where Jana Care is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Jana Care business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Diagnostic Test Platform: Self-administered blood testing platform for chronic kidney and heart disease management. The platform includes paper-based test strips and the Aina device reader. Prescription-based tests performed at home with results transmitted to healthcare providers.
- Connected Healthcare Services: Transmission of diagnostic results to physicians enabling telehealth visits. Connected platform enables ongoing monitoring of chronic disease patients.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Jana Care product offering
Product offeringCore offering
Jana Care develops and manufactures paper-based dry chemistry blood diagnostic test strips combined with a smartphone-paired optical reader device called the Aina for chronic disease biomarker monitoring. The platform enables self-administered, prescription-based blood testing at home for chronic kidney disease and congestive heart failure, transmitting results to physicians to enable telehealth visits with diagnostic testing. The technology transfers wet lab chemistry to dry chemistry strips that use capillary action to drive blood flow and produce readable signals for multiple assay types.
Product overview
Jana Care offers a diagnostic platform comprising the Aina Device (a smartphone-connected optical reader), paper-based test strips (dry chemistry tests for biomarkers), and connected software that transmits results to physicians for telehealth visits. The platform supports chronic disease management through biomarker-assisted monitoring. Supplementary offerings include the Aina Station device variant and the Habits Program. The self-administered blood testing platform specifically targets chronic kidney and heart disease management with remote monitoring capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- Aina: A smartphone-based optical reader device that reads paper-based diagnostic test strips for chronic disease monitoring
- Aina Station
- Habits Program
Products and services
- Aina Device A smartphone-paired optical reader device that reads paper-based test strips using colorimetric and fluorescent modalities, enabling multiple assays to be analyzed on a single compact, affordable reader for chronic disease biomarker monitoring.
- Paper-based Test Strips Dry chemistry diagnostic test strips for biomarkers relevant to home monitoring of chronic diseases, using immunoassays, enzymatic assays, and chemical affinity assays driven by capillary blood flow across porous materials coated with dry chemistry reagents.
- Aina Station Station configuration variant of the Aina diagnostic device referenced in Jana Care product documentation, intended for clinical or stationary use settings.
- Habits Program Chronic disease management program integrating Jana Care's diagnostic testing with telehealth workflows for ongoing patient monitoring.
- Self-Administered Blood Testing Platform Prescription-based platform enabling patients to perform blood tests at home for chronic kidney and heart disease management, with results transmitted to physicians to enable telehealth visits that include diagnostic testing.
Quantifiable outcome
- 1500+ clinics using the platform
- +2 more outcomes
Companies that use Jana Care
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles1 record
Jana Care technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Jana Care partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Siemens Healthineers IndiacoreSiemens Healthineers India introduced Jana Care's Aina diagnostic platform to address chronic diseases in India, representing a significant commercial partnership for the technology.
- National University Hospital (NUH) SingaporecoreNUH developed a smartphone app to help manage gestational diabetes in partnership with Jana Care, validating the platform for diabetes management applications.
- Massachusetts General HospitalcoreMass General Hospital launched a clinical study to evaluate Jana Care's mobile app for heart failure management, demonstrating clinical validation of the technology.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
Jana Care competitors and assessment
Company assessmentDirect peers
- Healthy.io: Healthy.io turns smartphones into clinical-grade diagnostic readers (starting with urinalysis) for at-home kidney disease screening. Directly comparable to Jana Care's smartphone-coupled, paper-strip-based at-home diagnostic platform targeting chronic kidney patients.
- Cue Health: Cue Health makes a connected at-home molecular and health diagnostic device with cartridge-based consumables. Comparable to Jana Care's Aina reader-and-strip connected diagnostic model, including the DTC/clinical dual-channel distribution approach.
- Babson Diagnostics: Babson Diagnostics is developing at-home and retail blood sample collection with small-volume capillary sampling for routine diagnostics. Comparable to Jana Care's at-home, capillary-blood-based chronic-disease testing approach via a connected reader.
- Everlywell: Everlywell offers consumer and clinician-ordered at-home diagnostic test kits across chronic and infectious disease biomarkers. Comparable to Jana Care in the at-home diagnostic channel and chronic-disease test menu, though with a kit-based rather than reader-based model.
- BioIQ: BioIQ is a health-testing platform that connects consumers, employers, and providers to diagnostic testing and remote monitoring programs. Comparable to Jana Care on the connected-telehealth-with-diagnostics model and on the chronic-disease management positioning.
- LetsGetChecked: LetsGetChecked offers at-home self-collected diagnostic tests (including chronic disease biomarkers) with physician follow-up and a connected results platform. Comparable to Jana Care on at-home blood-based chronic-disease testing integrated with telehealth.
Broad incumbents
- Abbott (i-STAT and FreeStyle Libre): Abbott operates the i-STAT point-of-care handheld diagnostics platform and FreeStyle Libre continuous glucose/strip ecosystem for chronic disease monitoring. Broad incumbent across the POC and chronic-disease diagnostic categories where Jana Care competes.
- Roche Diagnostics: Roche Diagnostics is a global leader in IVD reagents, POC devices (cobas), and chronic disease biomarker assays. Represents the established IVD/substance manufacturer that Jana Care's paper-strip technology must displace in primary-care settings.
- Siemens Healthineers: Siemens Healthineers is both an existing Jana Care partner (introduced Aina in India) and a broad incumbent in IVD and POC diagnostics. Overlap is direct on the product side and partner-based on the commercial side.
Emerging players
- AliveCor (KardiaMobile): AliveCor makes smartphone-connected ECG devices and a chronic-disease (cardiac) management platform for at-home use. Comparable to Jana Care on smartphone-coupled, at-home, connected chronic-disease monitoring with a physician-telehealth loop.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Jana Care social profiles
Digital presenceJana Care financial estimates
Financial estimateRevenue estimate
Valuation estimate
Jana Care leadership team
Management profileNumber of profiles
Profiles4 records
Jana Care subsidiaries and ownership
Company hierarchySubsidiaries1 record
Jana Care funding detail
Funding detailFunding overview
Funding rounds2 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Jana Care M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Jana Care
What does Jana Care do?
Jana Care develops and manufactures paper-based dry chemistry blood diagnostic test strips combined with a smartphone-paired optical reader device called the Aina for chronic disease biomarker monitoring. The platform enables self-administered, prescription-based blood testing at home for chronic kidney disease and congestive heart failure, transmitting results to physicians to enable telehealth visits with diagnostic testing. The technology transfers wet lab chemistry to dry chemistry strips that use capillary action to drive blood flow and produce readable signals for multiple assay types.
Is Jana Care a public or private company?
Jana Care is a private company. It is classified as venture growth investor backed and is currently operating.
When was Jana Care founded?
Jana Care was founded in 2015. It employs 51 to 100 people.
Where is Jana Care based?
Jana Care is headquartered in Boston, United States, in the North America region.
How does Jana Care make money?
Two revenue lines are on record. Diagnostic Test Platform is the primary driver. The others are connected Healthcare Services.
Who are Jana Care's main competitors?
Direct peers on record are Healthy.io, Cue Health, Babson Diagnostics, Everlywell, BioIQ and LetsGetChecked. Broad incumbents are Abbott (i-STAT and FreeStyle Libre), Roche Diagnostics and Siemens Healthineers. AliveCor (KardiaMobile) is listed as an emerging player.
Does Jana Care have an API?
No public API is recorded for Jana Care.
What industry is Jana Care in?
Jana Care's product category is Connected Diagnostic Devices. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices). Its NAICS code is 325413 and its SIC code is 2835.